We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery Better for Herniated Lumbar Discs

By HospiMedica International staff writers
Posted on 08 Jan 2014
For patients with herniated discs in the lumbar spine, surgery leads to greater long-term improvements compared to nonsurgical treatment, according to a new study.

Researchers at Dartmouth-Hitchcock Medical Center (Lebanon, NH, USA) and Dartmouth College (Hanover, NH, USA) conducted an eight-year follow-up of the Spine Patient Outcomes Research Trial (SPORT). More...
The study enrolled 501 participants with lumbar intervertebral disc herniation, and 743 observational cohorts at 13 spine clinics in 11 US states. Interventions involved standard open discectomy or nonsurgical treatment, such as physical therapy, exercise, and pain-relieving medications. The main outcome measures were changes from baseline in the SF-36 Bodily Pain and Physical Function scales and the modified Oswestry Disability Index (ODI).

The results showed that when outcomes were compared for patients who actually underwent surgery, pain scores averaged about 11 points lower in the surgery group. Measures of physical functioning and disability showed similar differences. Surgery also led to greater improvement in outcomes such as sciatica symptoms, patient satisfaction, and self-rated improvement. But while average outcome scores were better with surgery, many patients did have significant improvement with nonsurgical treatment, especially the one-third of patients who were slated for surgery but chose not to have operative treatment. The study was published in the January 1, 2014, issue of Spine.

“Surgery was superior to non-operative treatment in relieving symptoms and improving function; peak benefits are achieved within six months after surgery, and persist through eight years,” concluded lead author Jon Lurie, MD, MS, and colleagues. “However, many patients treated without surgery also showed substantial improvements over time. Patients who crossed over to surgery were more likely to be dissatisfied with their symptoms, felt like their symptoms were getting worse, and had initially worse physical function and disability.”

“Every patient in the SPORT study went through shared decision-making, during which they reviewed objective information about the risks and benefits of their treatment options. This allowed them to make an informed choice, in line with their own values,” commented SPORT principal investigator James Weinstein, MD. “That about a third of these patients have continued to be satisfied with their choice is in large part due, I believe, to their being active participants in the initial decision-making process.”

Related Links:

Dartmouth-Hitchcock Medical Center
Dartmouth College



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.